Sign in Subscribe
Machine learning

Global Drug Discovery Platforms Market to Reach USD 512.9 Mn by 2032 with 13.5% CAGR

Strategic Insights

— 1 min read

The global drug discovery platforms market is undergoing significant expansion, driven by technological innovation and increasing research and development investments. Experts are leveraging high-throughput screening, AI-driven modeling, and advanced microfluidics to accelerate candidate identification. By 2025, the market size is estimated to be valued at USD 211.3 Mn, with a projected compound annual growth rate (CAGR) of 13.5% from 2025 to 2032, reaching USD 512.9 Mn.

Key Takeaways:

  • North America leads in AI-integrated screening, driven by biopharma hubs in Boston and San Francisco, with 65% of initial screening outsourced to specialized platforms in 2024.
  • Latin America sees growing collaboration with academic centers in Brazil and Mexico, fueling assay development.
  • Europe experiences strong government grants in the UK, Germany, and Switzerland, supporting genomics platforms.
  • Asia Pacific witnesses rapid CDMO expansion in China and India, boosting microfluidics deployments.
  • Middle East investments in precision medicine initiatives across GCC states drive market growth.
  • Africa emerging research consortia in South Africa adopt cloud-based virtual screening.

Statistics:

  • The market is projected to grow from USD 211.3 Mn in 2025 to USD 512.9 Mn by 2032 at a CAGR of 13.5%.
  • Over 10 Bn assays capacity in global HTS facilities by 2025, up 18% since 2023.
  • Average per-assay cost dropped from USD 3.20 in 2023 to USD 2.75 in 2024, widening market opportunities.
  • Asia Pacific platforms exported USD 150 M worth of microfluidic chips in 2024, growing 30% YoY.
  • Initiatives reduce assay waste by 15% in leading North American labs by 2024.

Sources:

  • M2 PressWIRE (June 19, 2025)
  • Coherent Market Insights (C)1994-2025 M2 COMMUNICATIONS RDATE:18062025
  • Drug Discovery Platforms Market, By Drug Type (Small Molecule and Large Molecule), By Technology (Genomics, Proteomics, Cell-Based Assays, High-Throughput Screening, Bioinformatics, Next-Generation Sequencing, Mass Spectrometry, Imaging Technologies, Microfluidics, and Artificial Intelligence & Machine Learning), By Therapeutic Area (Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease)
  • Request Sample Copy of this Report (Use Corporate eMail ID to Get Higher Priority) at: https://www.coherentmarketinsights.com/insight/request-sample/7896
  • Book the Latest Edition of this Market Study Get Up to 25 % Discount: https://www.coherentmarketinsights.com/insight/buy-now/7896

Read more